<--- Back to Details
First PageDocument Content
HuMax / CD20 / Winkel / Pharmacology / Biology / Pharmaceutical industry / Genmab / Ofatumumab / Monoclonal antibodies
Date: 2015-03-05 03:24:54
HuMax
CD20
Winkel
Pharmacology
Biology
Pharmaceutical industry
Genmab
Ofatumumab
Monoclonal antibodies

Q&A GENMAB 4TH OF MARCH 2015 WITH JAN VAN DE WINKEL Q&A GENMAB 4TH OF MARCH 2015

Add to Reading List

Source URL: www.proinvestor.com

Download Document from Source Website

File Size: 304,80 KB

Share Document on Facebook

Similar Documents

Release Notes Software DECCAAHumax CXHD-5100C Update der Software des Interaktiven HD-Rekorders Humax CXHD-5100C auf Version DECCAA

Release Notes Software DECCAAHumax CXHD-5100C Update der Software des Interaktiven HD-Rekorders Humax CXHD-5100C auf Version DECCAA

DocID: 1swhZ - View Document

Q&A GENMAB 8TH OF MAY 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 8TH OF MAY 2014

Q&A GENMAB 8TH OF MAY 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 8TH OF MAY 2014

DocID: 16V15 - View Document

Q&A GENMAB 14TH OF AUGUST 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 14TH OF AUGUST 2014

Q&A GENMAB 14TH OF AUGUST 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 14TH OF AUGUST 2014

DocID: 16Dah - View Document

Q&A GENMAB 6TH OF NOVEMBER 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 6TH OF NOVEMBER 2014

Q&A GENMAB 6TH OF NOVEMBER 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 6TH OF NOVEMBER 2014

DocID: 16zwR - View Document

Q&A GENMAB 15. AUGUST 2013 MED JAN VAN DE WINKEL Q&A GENMAB 15. AUGUST 2013

Q&A GENMAB 15. AUGUST 2013 MED JAN VAN DE WINKEL Q&A GENMAB 15. AUGUST 2013

DocID: 16tFo - View Document